© 2024 WUTC
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
"Scenic Roots" offers conversations that matter in the heart of Chattanooga and the Tennessee Valley.From the mountains to the river, our conversations are rooted deep within every corner of our community - reflecting who we are, who we were and who we can become.We engage with the news that affects our community, behind and beyond the headlines. We build bridges that span from creators and innovators to storytellers and the outdoors. We focus on our challenges as many communities in one - as we celebrate what inspires us. We resonate with countless voices - in words and spaces, sounds and songs.We are "Scenic Roots."Ray Bassett hosts and produces "Scenic Roots" at WUTC.

From UTC ... To Studying Hydroxycholorquine

19 graphic
Unsplash.Com

Dr. Matthew Pullen earned his degree from this campus - the University of Tennessee at Chattanooga - in molecular biology.

He is now at the University of Minnesota’s Department of Medicine - and one of the researchers behind a study published last month in The New England Journal of Medicine on hydroxycholorquine.

The prescription drug successfully treats lupus, rheumatoid arthritis and malaria.  

Dr. Pullen and colleagues at three universities in Canada ran the first randomized clinical trial of the drug after exposure from the coronavirus - and found it was not effective in slowing down the replication of the virus.

Dr. Matthew Pullen
Credit UTC
Dr. Matthew Pullen

Related Content